Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Strecker Reagent. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102933589A details high-yield asymmetric Strecker reactions using novel N-phosphonimides, offering >99% ee for pharmaceutical intermediate manufacturing.